 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              The Compensation Committee of Directors of Ajanta Pharma Ltd at its meeting held on May 06, 2016, has allotted 3,750 fully paid up equity shares of Rs. 2/- each. These shares have been allotted upon exercise of options granted to an employee under Employees Stock Option Scheme - 2011 of the Company.
In view of the above, the paid up capital of the Company stand increased to Rs. 17,60,10,000 consisting 8,80,05,000 equity shares of Rs. 2/- each.
Shares of AJANTA PHARMA LTD. was last trading in BSE at Rs.1542.15 as compared to the previous close of Rs. 1517.55. The total number of shares traded during the day was 13637 in over 1229 trades.
The stock hit an intraday high of Rs. 1548 and intraday low of 1515.85. The net turnover during the day was Rs. 20934174.